# Executive Summary

**Outcome.** Synthetic and test data managed as **governed, auditable assets** — cataloged with
lineage, classified, approved before shared use, and access-controlled — aligned to the
organization's HIPAA/HITRUST and enterprise data-governance obligations. The synthetic-data
capability scales across service lines without accumulating shadow data risk.

**The problem.** In a regulated healthcare enterprise, synthetic and test datasets multiply quickly:
generated, forked, copied into AI sandboxes, and shared between QA teams. Left ungoverned they
become a shadow risk — no recorded origin, no classification, no approval, no evidence of alignment
to the standards the organization is held to. Even artificial data needs governance when it lives
inside a regulated estate.

**The approach.** This solution establishes six connected governance components — a policy and roles,
a catalog with lineage, a classification scheme, an enforced approval workflow, an access model, and
a control mapping to the organization's declared control set. It is delivered as a self-guided method
plus five Python tools, and follows a pilot-first **Assess → Design → Generate/Build → Validate →
Expand** model with explicit pass/fail gates (lineage → classification → approval → access → control
evidence) and a defined rollback. Prove it on one service line, then expand.

**Why it is safe.** The governance registers are **metadata-only** and never hold real Protected
Health Information; the category rule — never real PHI into a shared harness, twin, or AI test
environment — is preserved throughout. Every tool is safe-by-default (dry-run where it writes) and
standard-library-first with no invented network calls. Critically, the solution draws a **bright
line**: it delivers governance **method and evidence** — the catalog, classification records,
approval decisions, and control-alignment view — and **defers the determinations** (HIPAA/HITRUST
de-identification adequacy, disclosure-risk acceptance, IRB/privacy sign-off, control sufficiency) to
the organization's privacy, compliance, and legal functions. Green tool output is evidence for those
functions to interpret, never a compliance sign-off.

**The bottom line.** Synthetic/test data becomes a set of governed, cataloged, classified, approved,
and access-controlled assets aligned to HIPAA/HITRUST — so the capability scales safely — at a
fraction of the cost of a bespoke consulting engagement.
